Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 966,777 | 1,038,624 | 868,565 | 1,233,877 | 2,115,869 |
| Marketable Securities | 1,022,597 | 1,033,860 | 1,059,454 | 779,548 | N/A |
| Receivables | 214,628 | 201,509 | 203,854 | 178,194 | 152,990 |
| Inventories | 203,968 | 221,192 | 208,095 | 198,997 | 186,212 |
| Other current assets | 149,891 | 130,744 | 129,332 | 140,331 | 149,028 |
| TOTAL | $2,557,861 | $2,625,929 | $2,469,300 | $2,530,947 | $2,604,099 |
| Non-Current Assets | |||||
| PPE Net | 180,037 | 181,005 | 183,292 | 187,248 | 191,156 |
| Intangibles | 0 | 13,057 | 13,062 | 13,328 | 14,239 |
| Other Non-Current Assets | 390,468 | 336,158 | 331,199 | 324,631 | 338,480 |
| TOTAL | $570,505 | $530,220 | $527,553 | $525,207 | $543,875 |
| Total Assets | $3,128,366 | $3,156,149 | $2,996,853 | $3,056,154 | $3,147,974 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 95,875 | 118,461 | 56,207 | 54,007 | 76,741 |
| Accrued Expenses | 418,996 | 368,998 | 383,699 | 293,908 | 271,697 |
| Other current liabilities | N/A | 26,213 | 16,416 | 17,803 | 15,051 |
| TOTAL | $619,604 | $602,916 | $545,566 | $454,962 | $452,733 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,544,292 | 1,542,770 | 1,100,873 | 1,098,847 | 1,096,876 |
| Deferred Revenues | 89,244 | 89,244 | 89,244 | 89,244 | 89,244 |
| Other Non-Current Liabilities | 94,520 | 72,129 | 93,968 | 93,220 | 96,112 |
| TOTAL | $2,123,812 | $2,122,393 | $1,724,830 | $1,744,306 | $1,767,232 |
| Total Liabilities | $2,743,416 | $2,725,309 | $2,270,396 | $2,199,268 | $2,219,965 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,982 | 87,783 | 87,568 | 87,501 | 87,150 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -3,910,236 | -3,800,992 | -3,543,254 | -3,311,773 | -3,206,748 |
| Other shareholders' equity | -1,664 | -3,205 | -2,485 | -306 | -20 |
| TOTAL | $384,950 | $430,840 | $726,457 | $856,886 | $928,009 |
| Total Liabilities And Equity | $3,128,366 | $3,156,149 | $2,996,853 | $3,056,154 | $3,147,974 |